NKNeil Kitchen

Neil Kitchen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Neil Kitchen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Automated Operative Phase and Step Recognition in Vestibular Schwannoma Surgery: Development and Preclinical Evaluation of a Deep Learning Neural Network (IDEAL Stage 0)

    by Simon C. Williams, Dorothée Duvaux, Adrito Das, Siddharth Sinha, Hugo Layard Horsfall, Jonathan P. Funnell, John G. Hanrahan, Danyal Z. Khan, William Muirhead, Neil Kitchen, et al.

    BACKGROUND AND OBJECTIVES: Machine learning (ML) in surgical video analysis offers promising prospects for training and decision support in surgery. The past decade has seen key advances in ML-based operative workflow analysis, though existing applications mostly feature shorter surgeries (5 hours duration), data-heavy surgeries, using VS resection as an exemplar. METHODS: A video dataset of 21 microscopic retrosigmoid VS resections was collected at a single institution over 3 years and underwent workflow annotation according to a previously agreed expert consensus (Approach, Excision, and Closure phases; and Debulking or Dissection steps within the Excision phase). Annotations were used to train a ML model consisting of a convolutional neural network and a recurrent neural network. 5-fold cross-validation was used, and performance metrics (accuracy, precision, recall, F1 score) were assessed for phase and step prediction. RESULTS: Median operative video time was 5 hours 18 minutes (IQR 3 hours 21 minutes-6 hours 1 minute). The “Tumor Excision” phase accounted for the majority of each case (median 4 hours 23 minutes), whereas “Approach and Exposure” (28 minutes) and “Closure” (17 minutes) comprised shorter phases. The ML model accurately predicted operative phases (accuracy 81%, weighted F1 0.83) and dichotomized steps (accuracy 86%, weighted F1 0.86). CONCLUSION: This study demonstrates that our ML model can accurately predict the surgical phases and intraphase steps in retrosigmoid VS resection. This demonstrates the successful application of ML in operative workflow recognition on low-volume, lengthy, data-heavy surgical videos. Despite this, there remains room for improvement in individual step classification. Future applications of ML in low-volume high-complexity operations should prioritize collaborative video sharing to overcome barriers to clinical translation.


  • Open Access

    Suppression of tumour growth from transplanted astrocytoma cells transfected with luciferase in mice by bioluminescence mediated, systemic, photodynamic therapy

    by Jane Ng, Nico Henriquez, Neil Kitchen, Norman Williams, Marco Novelli, Dahmane Oukrif, Alexander MacRobert, Stephen Bown


  • Brain fragments: daily notes and reminiscences

    by Neil Kitchen

    This small and short book of less than 200 pages is an absolute must for every neurosurgeon particularly those interested in our profession’s history and development during the 20th century. Writte...


  • Top Cited Papers
    Open Access

    Survival Outcomes and Prognostic Factors in Glioblastoma

    by Nicholas F. Brown, Diego Ottaviani, John Tazare, John Gregson, Neil Kitchen, Sebastian Brandner, Naomi Fersht, Paul Mulholland

    Background: IDH-wildtype glioblastoma is the most common malignant primary brain tumour in adults. As there is limited information on prognostic factors outside of clinical trials; thus, we conducted a retrospective study to characterise the glioblastoma population at our centre. Methods: Demographic, tumour molecular profiles, treatment, and survival data were collated for patients diagnosed with glioblastoma at our centre between July 2011 and December 2015. We used multivariate proportional hazard model associations with survival. Results: 490 patients were included; 60% had debulking surgery and 40% biopsy only. Subsequently, 56% had standard chemoradiotherapy, 25% had non-standard chemo/radio-therapy, and 19% had no further treatment. Overall survival was 9.2 months. In the multivariate analysis, longer survival was associated with debulking surgery vs. biopsy alone (14.9 vs. 8 months) (HR 0.54 [95% CI 0.41–0.70]), subsequent treatment after diagnosis (HR 0.12 [0.08–0.16]) (standard chemoradiotherapy [16.9 months] vs. non-standard regimens [9.2 months] vs. none [2.0 months]), tumour MGMT promotor methylation (HR 0.71 [0.58–0.87]), and younger age (hazard ratio vs. age < 50: 1.70 [1.26–2.30] for ages 50–59; 3.53 [2.65–4.70] for ages 60–69; 4.82 [3.54–6.56] for ages 70+). Conclusions: The median survival for patients with glioblastoma is less than a year. Younger age, debulking surgery, treatment with chemoradiotherapy, and MGMT promotor methylation are independently associated with longer survival.


  • Surgery for cerebral cavernous malformations: a systematic review and meta-analysis

    by Lauren Harris, Michiel H. F. Poorthuis, Patrick Grover, Neil Kitchen, Rustam Al-Shahi Salman

    Background We sought to quantify the risks of neurosurgical excision of cerebral cavernous malformations (CCMs) in a systematic review of cohort studies. Methods We updated our previous systematic review by searching OVID Medline, OVID EMBASE, and the Cochrane Library from 1 January 2013 to 30 April 2019. The primary outcome was a composite of death attributed to CCM or surgery, non-fatal symptomatic intracerebral haemorrhage (ICH), or new or worsened persistent non-haemorrhagic focal neurological deficit (FND). Results We included 70 cohorts, 67 reporting surgery alone, and three compared surgery to conservative management. A total of 5,089 patients (median age 36 years, 52% female) underwent surgery (total follow-up 19,404 patient-years). The annual rate of the composite outcome was 4.2% (95% CI 2.9 to 5.7; 46 cohorts; I2 = 93%), which was higher in cohorts reporting exclusively brainstem CCM (6.0%, 95% CI 4.1–8.3; 25 cohorts, I2 = 92%) versus predominantly supratentorial CCM (2.4%, 95% CI 1.3–3.8, 21 cohorts, I2 = 86%, phet = 0.001). The annual rate of the composite outcome was higher in cohorts with > 95% presenting with ICH (6.1%, 95% CI 4.2–8.4; 23 cohorts, I2 = 93%) versus others (2.3%, 95% CI 1.2–3.7; 23 cohorts, I2 = 83%, phet = 0.001). The incidence of the composite outcome did not change over time in cohorts of exclusively brainstem CCM (p = 0.7) or predominantly supratentorial CCM (p = 0.5). Conclusions The risk of death, ICH, or FND after CCM excision is ~ 4%. This risk is higher for brainstem CCM and CCM that have caused ICH but has not changed over time. Trial registration This systematic review was registered (PROSPERO CRD42019131246).